Phase II study of safusidenib erbumine in patients with chemotherapy- and radiotherapy-naïve isocitrate dehydrogenase 1-mutated WHO grade 2 gliomas

Safusidenib erbumine is a potential treatment option for patients with chemotherapy- and radiotherapy-naïve IDH1-mutated WHO grade 2 gliomas.

Authors

Institutions

Publication Details

Journal
Neuro-Oncology
Published
2025-11-08
DOI
https://doi.org/10.1093/neuonc/noaf258
Citations
1
Primary Topic
Glioma Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
1.63

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Phase II study of safusidenib erbumine in patients with chemotherapy- and radiotherapy-naïve isocitrate dehydrogenase 1-mutated WHO grade 2 gliomas

Yasuyuki Kakurai, Yonehiro Kanemura, Daisuke Kuga, Akitake Mukasa et al.
1 citations
Neuro-Oncology
Glioma Diagnosis and Treatment
1.63
article

Phase II study of safusidenib erbumine in patients with chemotherapy- and radiotherapy-naïve isocitrate dehydrogenase 1-mutated WHO grade 2 gliomas

Yasuyuki Kakurai, Yonehiro Kanemura, Daisuke Kuga, Akitake Mukasa, Ryuta Saito, Shunichi Koriyama, Kazuya Motomura, Yoshiki Arakawa, Masayuki Kanamori, Kazuhiko Mishima, Fumiyuki Yamasaki, Kazuhiko Sugiyama, Motoo Nagane, Yoshitaka Narita, Toshihiro Kumabe, Koji Isobe, Hideo Nakamura
article en
1 citations

Abstract

Safusidenib erbumine is a potential treatment option for patients with chemotherapy- and radiotherapy-naïve IDH1-mutated WHO grade 2 gliomas.

Neuro-Oncology
Kurume University (JP), Kyushu University (JP), Daiichi Sankyo (Germany) (DE), Kyorin University (JP), Tohoku University (JP), Kyoto University (JP), National Cancer Center (US), Research Institute for Innovation and Technology (BR), Osaka National Hospital (JP), Daiichi-Sankyo (Japan) (JP), Hiroshima University Hospital (JP), Daiichi Sankyo (India) (IN), Saitama International Medical Center (JP), Tokyo Women's Medical University (JP), National Cancer Center Hospital East (JP), Nagoya University (JP), Kitasato University (JP), Saitama Medical University (JP), Kumamoto University (JP)
Daiichi-Sankyo, Daiichi Sankyo Europe
Openalex Percentile: Top 12%
Glioma Diagnosis and Treatment
1.63
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.